Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists

Bioorg Med Chem Lett. 2004 Dec 6;14(23):5881-4. doi: 10.1016/j.bmcl.2004.09.024.

Abstract

A series of tetrahydroisoquinolines has yielded potent MT(2) receptor antagonists, which are selective versus the MT(1) receptor.

MeSH terms

  • Humans
  • Protein Binding / physiology
  • Receptor, Melatonin, MT2 / antagonists & inhibitors*
  • Receptor, Melatonin, MT2 / metabolism*
  • Tetrahydroisoquinolines / chemistry*
  • Tetrahydroisoquinolines / metabolism*

Substances

  • Receptor, Melatonin, MT2
  • Tetrahydroisoquinolines